Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2025
Archives
Amphibole asbestos as a public health risk in 2025: Autoimmune disease
Despite efforts to minimize exposure, deaths from asbestos-related diseases remain high. A recent review emphasized the importance of evaluating different mineral groups and pointed out that exposure to amphibole asbestos is linked to higher rates of autoimmune diseases. Jean C. Pfau and Brenda J. Buck discuss the urgent need to address this public health risk more effectively.
Asbestos, the pleural cavity, and autoimmune disease
Jean C. Pfau, Ph.D. from the Center for Asbestos-Related Disease and Kinta Serve from Idaho State University, provide their perspective on asbestos, the pleural cavity, and autoimmune disease.
Asbestos disease pathogenesis: The long and short of it
Jean Pfau and Kinta Serve explore a critical and novel hypothesis concerning the size of fibers in asbestos disease pathogenesis.
Asbestos-induced autoantibodies across Libby demographics
Aiden Niblett, Jean Pfau, and Kinta Serve focus on asbestos-induced autoantibodies across different demographics in Libby. They emphasize the importance of understanding the impact of asbestos.
Exposure to Libby Amphibole: The clinical picture of autoimmune disease
Karen Lee Morrissette and Jean C. Pfau from the Center for Asbestos-Related Disease discuss the clinical presentation and complexity of the autoimmune disease progression among those exposed to Libby Amphibole.
Lessons from Libby: Understanding the impact of asbestos exposure
Jean C. Pfau, Scientific Consultant at the Center for Asbestos Related Disease, shares the devasting story of asbestos exposure occurring in a Rocky Mountain town of Montana and the critical lessons that can be learned from this event.
Dr Jean Pfau and the Center for Asbestos Related Disease (CARD)
Jean C. Pfau is an immunotoxicologist with a PhD in Microbiology and Biochemistry. Dr Pfau currently serves as a scientific consultant for the Center for Asbestos Related Disease (CARD) in Libby, Montana.
